Google
 
Google

World Stem Cell Summit 2010

Wednesday, February 18, 2009

British Journal of Cancer - Table of Contents alert Volume 100 Issue n4

BRITISH JOURNAL OF CANCER

Volume 100 Number 4
Published online 17 February 2009 (563 - 670)

----------------------------------------------------------------------

British Journal of Cancer publishes high quality original papers and
reviews that make a significant contribution to increasing
understanding of the causes of cancer and to improving the treatment
and survival of patients.

Visit the journal online at
http://links.ealert.nature.com/ctt?kn=58&m=31495330&r=MTc2MDAwMTgxNgS2&b=2&j=NDU5MDQ4NTMS1&mt=1&rt=0
to view the latest research and access selected articles FREE of charge.

----------------------------------------------------------------------

British Journal of Cancer has an impact factor 4.635*

*2007 Journal Citation Report (Thomson Reuters, 2008)

----------------------
CLINICAL STUDIES
----------------------
Cumulative survival in early-onset unilateral and bilateral breast
cancer: an analysis of 1907 Taiwanese women
W-H Kuo, A M-F Yen, P-H Lee, K-M Chen, J Wang, K-J Chang,
T H-H Chen and H-S Tsau
Abstract: http://links.ealert.nature.com/ctt?kn=36&m=31495330&r=MTc2MDAwMTgxNgS2&b=2&j=NDU5MDQ4NTMS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=31&m=31495330&r=MTc2MDAwMTgxNgS2&b=2&j=NDU5MDQ4NTMS1&mt=1&rt=0

The context and potential of epigenetics in oncology
J Lopez, M Percharde, H M Coley, A Webb and T Crook
Abstract: http://links.ealert.nature.com/ctt?kn=24&m=31495330&r=MTc2MDAwMTgxNgS2&b=2&j=NDU5MDQ4NTMS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=29&m=31495330&r=MTc2MDAwMTgxNgS2&b=2&j=NDU5MDQ4NTMS1&mt=1&rt=0

Circulating levels of leptin, adiposity and breast cancer risk
M-H Wu, Y-C Chou, W-Y Chou, G-C Hsu, C-H Chu, C-P Yu, J-C Yu and
C-A Sun
Abstract: http://links.ealert.nature.com/ctt?kn=43&m=31495330&r=MTc2MDAwMTgxNgS2&b=2&j=NDU5MDQ4NTMS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=55&m=31495330&r=MTc2MDAwMTgxNgS2&b=2&j=NDU5MDQ4NTMS1&mt=1&rt=0

Measuring, and identifying predictors of, women's perceptions of three
types of breast cancer risk: population risk, absolute risk and
comparative risk
C Apicella, S J Peacock, L Andrews, K Tucker, M B Daly and J L Hopper
Abstract: http://links.ealert.nature.com/ctt?kn=56&m=31495330&r=MTc2MDAwMTgxNgS2&b=2&j=NDU5MDQ4NTMS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=72&m=31495330&r=MTc2MDAwMTgxNgS2&b=2&j=NDU5MDQ4NTMS1&mt=1&rt=0

Contextual factors in shared decision making: a randomised controlled
trial in women with a strong suspicion of breast cancer
A Vodermaier, C Caspari, J Koehm, S Kahlert, N Ditsch and M Untch
Abstract: http://links.ealert.nature.com/ctt?kn=16&m=31495330&r=MTc2MDAwMTgxNgS2&b=2&j=NDU5MDQ4NTMS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=11&m=31495330&r=MTc2MDAwMTgxNgS2&b=2&j=NDU5MDQ4NTMS1&mt=1&rt=0

The total hospital and community UK costs of managing patients with
relapsed breast cancer
R J Thomas, M Williams, C Marshall, J Glen and M Callam
Abstract: http://links.ealert.nature.com/ctt?kn=27&m=31495330&r=MTc2MDAwMTgxNgS2&b=2&j=NDU5MDQ4NTMS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=50&m=31495330&r=MTc2MDAwMTgxNgS2&b=2&j=NDU5MDQ4NTMS1&mt=1&rt=0

Gemcitabine-oxaliplatin combination for ovarian cancer resistant to
taxane-platinum treatment: a phase II study from the GINECO group
I Ray-Coquard, B Weber, J Cretin, Z Haddad-Guichard, E Levy,
A C Hardy-Bessard, M C Gouttebel, J-F Geay, A Aleba, H Orfeuvre,
C Agostini, J Provencal, J M Ferrero, D Fric, N Dohollou, D Paraiso,
J Salvat and E Pujade-Lauraine
Abstract: http://links.ealert.nature.com/ctt?kn=6&m=31495330&r=MTc2MDAwMTgxNgS2&b=2&j=NDU5MDQ4NTMS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=99&m=31495330&r=MTc2MDAwMTgxNgS2&b=2&j=NDU5MDQ4NTMS1&mt=1&rt=0

Prognostic value of prostate circulating cells detection in prostate
cancer patients: a prospective study
P Eschwege, S Moutereau, S Droupy, R Douard, J-L Gala, G Benoit,
M Conti, P Manivet and S Loric
Abstract: http://links.ealert.nature.com/ctt?kn=41&m=31495330&r=MTc2MDAwMTgxNgS2&b=2&j=NDU5MDQ4NTMS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=32&m=31495330&r=MTc2MDAwMTgxNgS2&b=2&j=NDU5MDQ4NTMS1&mt=1&rt=0

Physical activity and colon cancer prevention: a meta-analysis
K Y Wolin, Y Yan, G A Colditz and I-M Lee
Abstract: http://links.ealert.nature.com/ctt?kn=53&m=31495330&r=MTc2MDAwMTgxNgS2&b=2&j=NDU5MDQ4NTMS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=67&m=31495330&r=MTc2MDAwMTgxNgS2&b=2&j=NDU5MDQ4NTMS1&mt=1&rt=0

Effect of portal vein embolisation on the growth rate of colorectal
liver metastases
V Pamecha, A Levene, F Grillo, N Woodward, A Dhillon and B R Davidson
Abstract: http://links.ealert.nature.com/ctt?kn=98&m=31495330&r=MTc2MDAwMTgxNgS2&b=2&j=NDU5MDQ4NTMS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=80&m=31495330&r=MTc2MDAwMTgxNgS2&b=2&j=NDU5MDQ4NTMS1&mt=1&rt=0

----------------------
TRANSLATIONAL THERAPEUTICS
----------------------
Epidermal growth factor receptor kinase domain mutations are rare
in salivary gland carcinomas
R Dahse, O Driemel, S Schwarz, J Dahse, K Kromeyer-Hauschild,
A Berndt and H Kosmehl
Abstract: http://links.ealert.nature.com/ctt?kn=7&m=31495330&r=MTc2MDAwMTgxNgS2&b=2&j=NDU5MDQ4NTMS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=22&m=31495330&r=MTc2MDAwMTgxNgS2&b=2&j=NDU5MDQ4NTMS1&mt=1&rt=0

Increased tumour dihydroceramide production after Photofrin-PDT
alone and improved tumour response after the combination with the
ceramide analogue LCL29. Evidence from mouse squamous cell
carcinomas
D Separovic, J Bielawski, J S Pierce, S Merchant, A L Tarca,
B Ogretmen and M Korbelik
Abstract: http://links.ealert.nature.com/ctt?kn=76&m=31495330&r=MTc2MDAwMTgxNgS2&b=2&j=NDU5MDQ4NTMS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=92&m=31495330&r=MTc2MDAwMTgxNgS2&b=2&j=NDU5MDQ4NTMS1&mt=1&rt=0

Regulation of focal adhesion turnover by ErbB signalling in
invasive breast cancer cells
Y Xu, N Benlimame, J Su, Q He and M A Alaoui-Jamali
Abstract: http://links.ealert.nature.com/ctt?kn=96&m=31495330&r=MTc2MDAwMTgxNgS2&b=2&j=NDU5MDQ4NTMS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=87&m=31495330&r=MTc2MDAwMTgxNgS2&b=2&j=NDU5MDQ4NTMS1&mt=1&rt=0

Carbogen breathing increases prostate cancer oxygenation: a
translational MRI study in murine xenografts and humans
R Alonzi, A R Padhani, R J Maxwell, N J Taylor, J J Stirling,
J I Wilson, J A d[prime]Arcy, D J Collins, M I Saunders and P J Hoskin
Abstract: http://links.ealert.nature.com/ctt?kn=91&m=31495330&r=MTc2MDAwMTgxNgS2&b=2&j=NDU5MDQ4NTMS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=94&m=31495330&r=MTc2MDAwMTgxNgS2&b=2&j=NDU5MDQ4NTMS1&mt=1&rt=0

----------------------
MOLECULAR DIAGNOSTICS
----------------------
Enhancement of the activity of phenoxodiol by cisplatin in
prostate cancer cells
R A C McPherson, P T Galettis and P L de Souza
Abstract: http://links.ealert.nature.com/ctt?kn=79&m=31495330&r=MTc2MDAwMTgxNgS2&b=2&j=NDU5MDQ4NTMS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=52&m=31495330&r=MTc2MDAwMTgxNgS2&b=2&j=NDU5MDQ4NTMS1&mt=1&rt=0

Overexpressed vs mutated Kras in murine fibroblasts: a
molecular phenotyping study
M Horsch, C V Recktenwald, S Schadler, M Hrabe de Angelis,
B Seliger and J Beckers
Abstract: http://links.ealert.nature.com/ctt?kn=18&m=31495330&r=MTc2MDAwMTgxNgS2&b=2&j=NDU5MDQ4NTMS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=38&m=31495330&r=MTc2MDAwMTgxNgS2&b=2&j=NDU5MDQ4NTMS1&mt=1&rt=0

----------------------
GENETICS AND GENOMICS
----------------------
DLEC1 is a functional 3p22.3 tumour suppressor silenced by
promoter CpG methylation in colon and gastric cancers
J Ying, F F Poon, J Yu, H Geng, A H Y Wong, G-H Qiu, H K Goh,
S Y Rha, L Tian, A T C Chan, J J Y Sung and Q Tao
Abstract: http://links.ealert.nature.com/ctt?kn=85&m=31495330&r=MTc2MDAwMTgxNgS2&b=2&j=NDU5MDQ4NTMS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=10&m=31495330&r=MTc2MDAwMTgxNgS2&b=2&j=NDU5MDQ4NTMS1&mt=1&rt=0

----------------------
LETTER TO THE EDITOR
----------------------
Regular dental check-ups could be of benefit for patients
receiving intravenous bisphosphonates. Regarding
'risks and benefits of bisphosphonates'
A Kyrgidis and S Triaridis
http://links.ealert.nature.com/ctt?kn=40&m=31495330&r=MTc2MDAwMTgxNgS2&b=2&j=NDU5MDQ4NTMS1&mt=1&rt=0

----------------------------------------------------------------------

Ensure your access to British Journal of Cancer

If you are unable to access the articles in this Table of Contents
e-alert, your library may not subscribe to this journal. Our online
recommendation form is a simple way to make your librarian aware that
this journal is valuable to your research.

Recommend now at
http://links.ealert.nature.com/ctt?kn=35&m=31495330&r=MTc2MDAwMTgxNgS2&b=2&j=NDU5MDQ4NTMS1&mt=1&rt=0.

=====================================================================

You have been sent this Table of Contents Alert because you have opted in to receive it.
You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at:
http://links.ealert.nature.com/ctt?kn=19&m=31495330&r=MTc2MDAwMTgxNgS2&b=2&j=NDU5MDQ4NTMS1&mt=1&rt=0
(You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department:
registration@nature.com

For print subscription enquiries, please contact our subscription department:
subscriptions@nature.com

For other enquiries, please contact customer feedback department:
feedback@nature.com

Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne - San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.

© Copyright 2009 Nature Publishing Group

=====================================================================

Google

Any Comments ?.......

E-mail: manojhind2001us@gmail.com
Google
 

World Time